SCHEMBL4895843

SCHEMBL4895843

CCN(c1ccc(Oc2ccc(Cl)cc2)cc1)S(=O)(=O)c1ccc(C)c(C(=O)OC)c1

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.50
TSHR P16473 1/20 0.50
MAPT P10636 6/20 0.48
LMNA P02545 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
NR3C1 P04150 1/20 0.46
PGR P06401 1/20 0.46
MCL1 Q07820 2/20 0.46
CNR2 P34972 1/20 0.45
KMT2A Q03164 1/20 0.45
TP53 P04637 2/20 0.45
OXTR P30559 1/20 0.43
AVPR1A P37288 1/20 0.43
ESR1 P03372 1/20 0.43
MMP2 P08253 1/20 0.43
MMP9 P14780 1/20 0.43
BCL2L1 Q07817 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4899320 0.92 ALDH1A1 (0.52) ALDH1A1TSHRMAPTLMNASMN1; SMN2
SCHEMBL4902668 0.91 ALDH1A1 (0.46) ALDH1A1TSHRMAPTLMNASMN1; SMN2
SCHEMBL4903818 0.91 ESR1 (0.52) ALDH1A1MAPTLMNASMN1; SMN2NR3C1
SCHEMBL4906523 0.90 LMNA (0.48) ALDH1A1TSHRMAPTLMNASMN1; SMN2
SCHEMBL4902984 0.90 ALDH1A1 (0.50) ALDH1A1TSHRMAPTLMNASMN1; SMN2
SCHEMBL4903997 0.90 MAPT (0.49) ALDH1A1TSHRMAPTLMNASMN1; SMN2
SCHEMBL4906805 0.89 LMNA (0.56) ALDH1A1MAPTLMNASMN1; SMN2NR3C1
SCHEMBL4895775 0.89 ALDH1A1 (0.48) ALDH1A1TSHRMAPTLMNASMN1; SMN2
SCHEMBL4895774 0.89 LMNA (0.51) ALDH1A1TSHRMAPTLMNASMN1; SMN2
SCHEMBL4906197 0.89 LMNA (0.51) ALDH1A1TSHRMAPTLMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds HAMANAKA ERNEST S 2006-10-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARA, PPARG, PPARD ALDH1A1 2664/4885TSHR 412/4885MAPT 1858/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD ALDH1A1 2956/4885TSHR 400/4885MAPT 1786/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.